You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
|
|---|---|
| Published in |
New England Journal of Medicine, August 2013
|
| DOI | 10.1056/nejmoa1306638 |
| Pubmed ID | |
| Authors |
Harry R Büller, Hervé Décousus, Michael A Grosso, Michele Mercuri, Saskia Middeldorp, Martin H Prins, Gary E Raskob, Sebastian M Schellong, Lee Schwocho, Annelise Segers, Minggao Shi, Peter Verhamme, Phil Wells |
X Demographics
The data shown below were collected from the profiles of 78 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 14 | 18% |
| United Kingdom | 7 | 9% |
| France | 6 | 8% |
| Canada | 2 | 3% |
| Japan | 2 | 3% |
| Italy | 2 | 3% |
| Netherlands | 1 | 1% |
| Argentina | 1 | 1% |
| Ecuador | 1 | 1% |
| Other | 6 | 8% |
| Unknown | 36 | 46% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 59 | 76% |
| Practitioners (doctors, other healthcare professionals) | 9 | 12% |
| Scientists | 7 | 9% |
| Science communicators (journalists, bloggers, editors) | 3 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 896 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | <1% |
| Netherlands | 3 | <1% |
| United Kingdom | 3 | <1% |
| Germany | 2 | <1% |
| France | 2 | <1% |
| Colombia | 2 | <1% |
| Brazil | 2 | <1% |
| Spain | 2 | <1% |
| Japan | 2 | <1% |
| Other | 6 | <1% |
| Unknown | 868 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 135 | 15% |
| Researcher | 118 | 13% |
| Student > Bachelor | 90 | 10% |
| Student > Master | 79 | 9% |
| Student > Postgraduate | 74 | 8% |
| Other | 229 | 26% |
| Unknown | 171 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 508 | 57% |
| Pharmacology, Toxicology and Pharmaceutical Science | 58 | 6% |
| Agricultural and Biological Sciences | 29 | 3% |
| Nursing and Health Professions | 18 | 2% |
| Biochemistry, Genetics and Molecular Biology | 13 | 1% |
| Other | 59 | 7% |
| Unknown | 211 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 423. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 October 2022.
All research outputs
#69,416
of 25,837,817 outputs
Outputs from New England Journal of Medicine
#2,041
of 32,687 outputs
Outputs of similar age
#405
of 215,148 outputs
Outputs of similar age from New England Journal of Medicine
#12
of 297 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,687 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,148 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 297 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.